Published in Thyroid on October 01, 2005
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid (2014) 1.01
Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep (2012) 0.90
Lack of association of VDR gene polymorphisms with thyroid autoimmune disorders: familial and case/control studies. J Clin Immunol (2007) 0.88
Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions. Curr Genomics (2011) 0.85
Influence of the vitamin D plasma level and vitamin D-related genetic polymorphisms on the immune status of patients with type 1 diabetes: a pilot study. Clin Exp Immunol (2013) 0.79
High frequency of vitamin D receptor gene polymorphism FokI in Brazilian Type 1 diabetes mellitus patients with clinical autoimmune thyroid disease. Diabetol Metab Syndr (2016) 0.76
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet (2006) 4.49
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet (2013) 2.45
Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol (2011) 2.40
Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes (2011) 1.78
CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev (2007) 1.74
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes (2007) 1.68
Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab (2007) 1.57
Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab (2005) 1.42
The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol (2007) 1.28
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol (2005) 1.21
Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation (2007) 1.13
Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) (2005) 1.11
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. J Immunother (2010) 1.11
A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol (2004) 1.11
Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol (2012) 1.10
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol Dis (2004) 1.09
Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci (2006) 1.08
Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol (2005) 1.06
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS One (2012) 1.05
Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metab (2004) 0.98
Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid (2005) 0.98
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol. Front Oncol (2013) 0.97
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. PLoS One (2011) 0.97
Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol (2013) 0.96
Vitamin D receptor genotype is associated with Addison's disease. Eur J Endocrinol (2002) 0.94
Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid (2009) 0.94
CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans. J Steroid Biochem Mol Biol (2004) 0.93
A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab (2002) 0.91
FOXE1 association with differentiated thyroid cancer and its progression. Thyroid (2014) 0.91
Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS One (2010) 0.90
Coeliac disease in endocrine diseases of autoimmune origin. Endokrynol Pol (2012) 0.90
Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J Clin Endocrinol Metab (2004) 0.90
Association between age at diagnosis of Graves' disease and variants in genes involved in immune response. PLoS One (2013) 0.90
Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur J Endocrinol (2002) 0.89
Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol (2003) 0.88
Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid (2012) 0.87
Polymorphism of the oestrogen receptor beta gene (ESR2) is associated with susceptibility to Graves' disease. Clin Endocrinol (Oxf) (2007) 0.86
[The influence of vitamin D deficiency on cancers and autoimmune diseases development]. Endokrynol Pol (2007) 0.86
Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood (2012) 0.86
CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients. J Steroid Biochem Mol Biol (2007) 0.86
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults. Endokrynol Pol (2010) 0.86
Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II. BMC Med Genet (2008) 0.86
PTPN22 1858T allele is associated with younger age at onset of type 1 diabetes and is not related to subsequent thyroid autoimmunity. Hum Immunol (2010) 0.85
[Management of thyroid diseases during pregnancy]. Endokrynol Pol (2011) 0.85
Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07. Thyroid (2006) 0.85
Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. J Clin Endocrinol Metab (2011) 0.85
Adrenal imaging. Endokrynol Pol (2012) 0.84
beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. Int J Mol Med (2007) 0.82
Diagnostics and Treatment of Thyroid Carcinoma. Endokrynol Pol (2016) 0.82
Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses. AIDS Res Hum Retroviruses (2007) 0.81
Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. J Clin Endocrinol Metab (2002) 0.81
Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol (2008) 0.81
The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease. BMC Med Genet (2009) 0.81
The genetic basis of graves' disease. Curr Genomics (2011) 0.81
Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. Circ Heart Fail (2012) 0.81
Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin Endocrinol (Oxf) (2002) 0.80
Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes? Pediatr Diabetes (2014) 0.80
The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes. Basic Res Cardiol (2009) 0.80
Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults. Diabetes Metab Res Rev (2013) 0.80
Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma. Eur J Clin Invest (2013) 0.79
Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin Endocrinol (Oxf) (2003) 0.79
TIM-3 polymorphisms in type 1 diabetes families. J Hum Genet (2008) 0.79
Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease. Hum Immunol (2003) 0.79
Aging is accompanied by a progressive decrease of expression of the WRN gene in human blood mononuclear cells. J Gerontol A Biol Sci Med Sci (2010) 0.79
CYP27B1 gene polymorphism is associated with Graves' disease in a Polish population study. Thyroid (2005) 0.78
Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity. Biogerontology (2009) 0.78
Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's Disease). Diabetes Technol Ther (2012) 0.78
The diagnostic criteria of Graves' disease and especially the thyrotropin receptor antibody; our own experience. Hell J Nucl Med (2007) 0.78
Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study. Thyroid Res (2009) 0.78
GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy. Endokrynol Pol (2015) 0.78
Prolonged preterm rupture of fetal membranes, a consequence of an increased maternal anti-fetal T cell responsiveness. Pediatr Res (2005) 0.77
Amiodarone and the thyroid. Endokrynol Pol (2015) 0.77
[Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy]. Med Klin (Munich) (2003) 0.77
Total and high molecular weight adiponectin and level-modifying polymorphisms of ADIPOQ in centenarians. Endokrynol Pol (2012) 0.77
Is high dose intravenous methylprednisolone pulse therapy in patients with Graves' orbitopathy safe? Endokrynol Pol (2014) 0.77
Can we accurately measure the concentration of clinically relevant vitamin D metabolites in the circulation? The problems and their consequences. Endokrynol Pol (2013) 0.77
Acromegaly--a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports. Endokrynol Pol (2014) 0.77
Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease. Neuroendocrinology (2012) 0.77
The role of cubilin gene polymorphisms and their influence on 25(OH)D3 and 1,25(OH)2D3 plasma levels in type 1 diabetes patients. J Steroid Biochem Mol Biol (2010) 0.77
No association of two Fas gene polymorphisms with Hashimoto's thyroiditis and Graves' disease. Eur J Endocrinol (2003) 0.77
The -351A/G polymorphism of ESR1 is associated with risk of myocardial infarction but not with extreme longevity. Clin Chim Acta (2010) 0.77
Functional polymorphisms of the leptin and leptin receptor genes are associated with longevity and with the risk of myocardial infarction and of type 2 diabetes mellitus. Endokrynol Pol (2014) 0.77
Solar power to prevent type 1 diabetes? Pediatr Diabetes (2008) 0.76
Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. Hum Immunol (2009) 0.76
Age-related changes of leptin and leptin receptor variants in healthy elderly and long-lived adults. Geriatr Gerontol Int (2014) 0.76
First trimester maternal serum vitamin D and markers of preeclampsia. J Matern Fetal Neonatal Med (2013) 0.76
Vitamin D insufficiency in healthy pregnant women living in Warsaw. Ginekol Pol (2013) 0.76
Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs). Endokrynol Pol (2015) 0.76
Increasing prevalence of Addison's disease in German females: health insurance data 2008-2012. Eur J Endocrinol (2014) 0.76
Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium. J Clin Endocrinol Metab (2012) 0.76
LC-MS/MS improves screening towards 21-hydroxylase deficiency. Gynecol Endocrinol (2014) 0.76
Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy. Endokrynol Pol (2016) 0.75
A CXC motif ligand 10 polymorphism as a marker to predict severity of Graves' disease. Thyroid (2010) 0.75
Distribution of TNFA haplotypes in healthy Caucasians: comment on the articles by Newton et al and Zeggini et al. Arthritis Rheum (2004) 0.75